Search - tctmd.com

Displaying 461 - 480 of 567

Sort: Relevancy | Date

News Daily News

El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia

March 06, 2012

News Daily News

El Estudio no Halla “Paradoja de la Obesidad” alguna en Pacientes Tratados con SLF

Jason Kahn

March 06, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Daily News

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

March 05, 2012

News Daily News

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

March 05, 2012

News Daily News

El Estudio PEPCAD-DES: El Balón recubierto de Paclitaxel es mejor que el Balón convencional para resolver la reestenosis de un SLF

March 05, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

News Industry News

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients

February 21, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Industry News

Eurocor GmbH announces presentation of Valentines Trial II results at CRT2012

February 07, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Industry News

Eurocor announces treatment of First Patients in International Randomized Freeride Study

January 24, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

November 10, 2011

Advertisement

El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia

El Estudio no Halla “Paradoja de la Obesidad” alguna en Pacientes Tratados con SLF

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

El Estudio PEPCAD-DES: El Balón recubierto de Paclitaxel es mejor que el Balón convencional para resolver la reestenosis de un SLF

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Eurocor GmbH announces presentation of Valentines Trial II results at CRT2012

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Eurocor announces treatment of First Patients in International Randomized Freeride Study

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Two New SES Show Improvement Over First-Generation Stents

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content